SIREN : 827932476
BIO FRONTON is a French company founded 9 years ago, specialized in the sector Commerce d'alimentation générale. Based in FRONTON (31620), this company of category PME shows in 2024 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 1 371 578 € | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 7 399 € | 9 030 € | -33 275 € | 1 277 € | 9 223 € | 17 407 € | -29 268 € |
| EBITDA | 39 354 € | N/C | N/C | N/C | N/C | N/C | N/C |
| Net margin | 0.5% | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, BIO FRONTON achieves revenue of 1.4 M€. After deducting consumption (977 k€), gross margin stands at 395 k€, i.e. a rate of 29%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 39 k€, representing 2.9% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 7 k€, i.e. 0.5% of revenue. This profit can be retained or distributed to shareholders.
1 371 578 €
395 067 €
39 354 €
17 917 €
7 399 €
2.9%
The debt ratio (= Financial debt / Equity x 100) stands at -2960%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -2%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 8.2 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 2.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
-2959.576%
-2.246%
2.152%
8.23
36.4%
In 2024, the debt ratio of BIO FRONTON (-2959.58) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of BIO FRONTON (-2.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of BIO FRONTON (8.23) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 150.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 13.5x. Operating income very largely covers interest expenses: high safety margin.
150.476
13.478
In 2024, the liquidity ratio of BIO FRONTON (150.48) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of BIO FRONTON (13.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 3 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 30 days. Favorable situation: supplier credit is longer than customer credit by 27 days. Inventory turnover is 32 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 30 days of revenue, i.e. 114 k€ to permanently finance.
113 567 €
3 j
30 j
32 j
30 j
Based on 551 transactions of similar company sales in 2024, the value of BIO FRONTON is estimated at 196 257 € (range 87 748€ - 391 371€). With an EBITDA of 39 354€, the sector multiple of 4.7x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 551 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIO FRONTON with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce d'alimentation générale
The revenue of BIO FRONTON in 2024 is 1.4 M€.
Yes, BIO FRONTON generated a net profit of 7 k€ in 2024.
The headquarters of BIO FRONTON is located in FRONTON (31620), in the department Haute-Garonne.
The tax return of BIO FRONTON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIO FRONTON operates in the sector Commerce d'alimentation générale (NAF code 47.11B). See the 'Sector positioning' section above to compare the company with its competitors.